Safe Biologics

JULY 20, 2023

On June 26th, ASBM Chairman Ralph McKibbin presented a poster at the DIA Global Annual Meeting in Boston, MA. Dr. McKibbin presents the poster findings View Dr. McKibbin’s video walkthrough of the poster Prior ASBM surveys across many specialties revealed that 83% of Canadian, 82% of European, and 69% of U.S.

Biosimilars 130

Biosimilars 130

STAT

NOVEMBER 30, 2023

Worried about your health? You can now avail yourself of noninvasive diagnostics that claim to screen for rare birth defects, cancer-associated mutations, and even Alzheimer’s.

Labelling 337

Labelling 337

Pharma Times

JANUARY 19, 2024

Company will present vital findings at SRI annual meeting

117

117

STAT

SEPTEMBER 3, 2024

Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that, while a success on paper, likely won’t satisfy many investors closely watching the AI drug developer. 

Drug Development 337

Drug Development 337

STAT

JULY 25, 2023

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal.

246

246

Safe Biologics

MARCH 21, 2024

On March 19th, ASBM presented to the World Health Organization International Nonpropretary Names (INN) Expert Group at the 78th Consultation on International Non-proprietary Names for Pharmaceutical Substances (INN), held in Geneva, Switzerland on October 18th, 2023. and Advisory Board Chair Philip Schneider, MS, FASHP.

Biosimilars 100

Biosimilars Labelling 100

Express Pharma

MAY 28, 2024

PRESENTATION OF CITATIONS Citation Category: Champion of Change + Mr Anil Damle + Ms Aruna Nayak + Mr Avinash Kumar Talwar + Mr Ashish Sabnis + Mr Deepak Khurana + Mr Ganesh Sabat + Mr Gaurav Suchak + Mr Kaifeel Shaikh + Mr Krishnakant Parab + Mr Nihar Medh + Mr Pramod Pandit + Mr Sachin Hujare The post Presentation of Citations: ‘Champion of (..)

52

52

STAT

MARCH 11, 2024

Hundreds of messages from an internal chat board for an international group of transgender health professionals were leaked in a think tank report last week and framed as revealing serious health risks associated with gender-affirming care, including cancer.

346

346

PharmaTech

MAY 8, 2024

The company is presenting preclinical data at the American Society of Gene & Cell Therapy annual meeting that supports the potential of the company’s CAP-002 gene therapy for correcting neurological phenotypes associated with genetic epilepsy due to syntaxin-binding protein 1 (STXBP1) mutations.

118

118

European Pharmaceutical Review

JULY 8, 2022

In an article published in the Journal of Validation Technology (JVT), pharmaceutical microbiologist and contamination control expert Tim Sandle identified ten categories of risk presented by aging. Degradation of the facilities, for instance cracks in walls or tears in material, can also present contamination challenges.

128

128

Express Pharma

SEPTEMBER 25, 2024

Biocon Biologics , a subsidiary of Biocon announced new dermatology data presented at the European Academy of Dermatology and Venereology (EADV) 2024 Congress in Amsterdam. The post Biocon Biologics announces new dermatology data to be presented at EADV Congress 2024 appeared first on Express Pharma.

Biosimilars 105

Biosimilars 105

European Pharmaceutical Review

OCTOBER 30, 2023

At present, there are no curative treatments for LGMD2I/R9. Additionally, these first results were also presented at the 2023 International Limb-Girdle Muscular Dystrophy Conference. According to Atamyo Therapeutics, the condition is characterised by progressive muscular weakness, leading to loss of the ability to walk independently.

98

98

RX Note

JUNE 25, 2023

If and only if I know how to engage with audience, why would I search how to do a good presentation? Instead of finding out how to make a marvellous presentation, why not start thinking What do we expect when we are the audience ? Not all information has to be included in CME presentation slide.

40

40

STAT

SEPTEMBER 17, 2024

Federal health officials wrestling with when and how to use artificial intelligence will on Wednesday host an invitation-only meeting of AI leaders across industry, academia, and government. Called “AI in Action: Transforming Health and Human Services,” the three-hour event is hosted by the federal health department.

Medical Schools 319

Medical Schools Hospitals 319

STAT

DECEMBER 20, 2023

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke. He is also trying to fight the long legacy of racism in neuroscience.

298

298

Safe Biologics

MARCH 30, 2023

The recently-published Executive Summary from the 75th INN Consultation, at which ASBM presented in October 2022, summarizes ASBM’s position regarding the value of distinct biologic nomenclature: One significant challenge to efficient global cooperation is the lack of harmonization.

Biosimilars 100

Biosimilars Labelling 100

World Pharma News

MARCH 4, 2024

Novartis today presented new data that continue to support the clinical benefits of Zolgensma® (onasemnogene abeparvovec), the only one-time gene therapy for the treatment of spinal muscular atrophy (SMA). Final data from the SMART study highlight the safety and efficacy profile of Zolgensma in children with SMA weighing ≥ 8.5

85

85

Pharmacy Times

NOVEMBER 20, 2024

Data from the BROADEN and PROGRESS studies were presented at the International Papillomavirus Conference 2024 in Edinburgh, UK, from November 12 to 15.

Vaccines 26

Vaccines 26

Pharmacy Times

APRIL 16, 2024

Sa’ed Al-Olimat, PharmD, co-founder of the Psychedelic Pharmacists Association, discussed the future of psychedelic medicines and the unique ethical challenges they present.

49

49

Outsourcing Pharma

NOVEMBER 29, 2021

The biotech firm has presented data from a study that could offer hope to patients with Parkinsonâs, Gaucher, Alzheimerâs and other neurodegenerative conditions.

115

115

World Pharma News

APRIL 16, 2024

(AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, on Sunday April 14 presented results from the 18-month Phase Ib clinical trial for AB-1005, an investigational gene therapy for treating patients with Parkinson's disease (PD).(1,2)

103

103

pharmaphorum

JUNE 7, 2022

This post makes a case for encouraging and supporting presenters in order to get the most out of their expertise. You’ve been invited to deliver a presentation. Presentation success is a ‘team sport’. Before you know it, your presentation is completely off the rails. Does your topic require a presentation?

Communication 98

Communication 98

European Pharmaceutical Review

SEPTEMBER 7, 2023

The post Alzheimer’s senescent cell combination therapy presents promise appeared first on European Pharmaceutical Review. A larger $3 million, Phase II clinical trial is in process, with the aim to test the effects of clearing senescent cells with the combination therapy, the paper noted.

98

98

European Pharmaceutical Review

JUNE 20, 2023

Key highlights from the presentation include: CHK-336 was generally well tolerated in HVs who received single doses up to 500mg and multiple doses (14 days) up to 60mg. Participants in the MAD portion of the study received placebo or multiple doses of the oral small molecule CHK-336, ranging from 30mg to 500mg given daily for 14 days.

98

98

Pharma Times

NOVEMBER 6, 2024

Phase 1 and 2 studies show promising results for anito-cel therapy

112

112

National Association of Boards of Pharmacy

NOVEMBER 13, 2024

The post Transformative Technologies Present Opportunities for Pharmacy Practice and Regulation appeared first on National Association of Boards of Pharmacy. This blog was adapted from an article that originally appeared in the September/October 2024 issue of Innovations.

Pharmacy Technician 45

Pharmacy Technician Patient Counseling 45

Pharmacy Times

JULY 18, 2024

Safety and efficacy findings on Lomecel-B will be presented at the upcoming 2024 Alzheimer’s Association International Conference, which will be held July 28 to August 1.

55

55

Express Pharma

SEPTEMBER 10, 2023

Results presented from the Phase III IMpower133 study and extension trial IMbrella A, show Roche’s Tecentriq (atezolizumab), in combination with chemotherapy, demonstrates a potential long-term overall survival (OS) benefit as first-line treatment for extensive-stage small cell lung cancer (ES-SCLC). Presented at WCLC 2023.

Chemotherapy 109

Chemotherapy 109

Pharma Mirror

APRIL 21, 2024

The post Exploring Periodontal Disease: Present Therapies, Emerging Treatments, and Beyond appeared first on Pharma Mirror Magazine. Untreated Periodontitis ultimately results in tooth loss, chronic inflammation, and pain. There are also a variety of systemic health effects linked to the disease which are even more detrimental.

52

52

PharmExec

JUNE 13, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Pedro Valencia, VP, Solid Tumor Pipeline Strategy & Execution, AbbVie, discusses data presented at ASCO from ABBV-400 and ABBV-706 in multiple studies.

52

52

STAT

NOVEMBER 11, 2024

  These four papers, being published Monday in scientific journals before being presented at the American Heart Association’s scientific sessions later this week in Chicago, focus on health disparities, linking who people are to how they fared: Read the rest…

324

324

PharmaTech

MAY 9, 2024

The company’s presentation at ASGCT includes preliminary data results for a child who received the gene therapy.

52

52

PharmExec

JUNE 13, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Pedro Valencia, VP, Solid Tumor Pipeline Strategy & Execution, AbbVie, discusses data presented at ASCO from ABBV-400 and ABBV-706 in multiple studies.

52

52

Pharmafile

SEPTEMBER 30, 2024

Vertex also announcedpresentations describing long- term outcomes […] The post Vertex Highlights First Oral Presentation of Phase 3 Clinical Dataof the Vanzacaftor Triple Combination and New Data on Long-Term Impact of TRIKAFTA at the North American CysticFibrosis Conference appeared first on Pharmafile.

59

59

European Pharmaceutical Review

AUGUST 25, 2022

The post Oncolytic viruses: past and present appeared first on European Pharmaceutical Review. human study of TK?positive positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells. J Transl med. 2019;17:271.

Immunization 111

Immunization Immunity Chemotherapy Packaging 111

Find Your Script

JUNE 4, 2022

Purchase Pharmacy Poster Presentation Templates here! The post How to Make a Pharmacy Poster Presentation appeared first on Find Your Script by Dr. Jessica Louie. We talk passive income and simplifying on this channel to combat stress and burnout. What to include? How to format it? Link to purchase. Best step to take? How to print it?

52

52

STAT

OCTOBER 30, 2024

The STAT Diversity and Inclusion Committee presents STAT’s 2024 Diversity and Inclusion Report. Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2023, as well as our 2023 new hire demographics. 

290

290